Newest first
New topics page 11
Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.
1,535 topics · page 11 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
A 5 mg vial and a 0.25 mg dose: the arithmetic in full
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
|
+124 | 141 | 16k | 2d |
|
Labelling requirements for research chemicals
Labelling requirements for research chemicals — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked for.…
|
+5 | 9 | 45k | 4mo |
|
Sample handling between despatch and injection
Sample handling between despatch and injection Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first, because I know what the first three replies will…
|
+63 | 68 | 2.4k | 3mo |
|
What to include when your question involves a laboratory result
Asking directly, because I could not find a straight answer: What to include when your question involves a laboratory result Question in the title. Context below, and I have tried to include the things people…
|
+8 | 12 | 14k | 2d |
|
Vomiting: when it is expected and when it is a reason to stop — one year on
Vomiting: when it is expected and when it is a reason to stop — one year on Writing it up because I had to work it out twice and would rather nobody else did. Reporting something rather than asking about it,…
|
+19 | 23 | 49k | 18h |
|
Does a peptide degrade silently, with no visual change?
Does a peptide degrade silently, with no visual change? I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this and I still have a…
|
+73 | 79 | 1.3k | 1d |
|
Revisiting: Mobile reading experience on long topics
Posting this under the heading it deserves: Revisiting: Mobile reading experience on long topics Everything below is what sits behind that. Nominating something for promotion into the documentation commons.…
|
+11 | 15 | 34k | 10h |
|
When a network meta-analysis is defensible and when it is not
When a network meta-analysis is defensible and when it is not I have a specific reason for asking rather than idle curiosity, and the context is below. Comparing SUSTAIN 6 ( N Engl J Med , 2016) with LEADER (…
|
2 | 27k | 4h | |
|
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters — setting out what I have, and where I think it stops being reliable. Practical question with the units stated, because I have seen how quickly…
|
+104 | 114 | 6k | 6d |
|
Shakes versus food: a pragmatic assessment
Shakes versus food: a pragmatic assessment Writing it up because I had to work it out twice and would rather nobody else did. Maintenance rather than loss, which is the part of this that almost nobody writes…
|
+22 | 26 | 53k | 20h |
|
Area percent versus weight percent: the confusion that causes most arguments
Posting this under the heading it deserves: Area percent versus weight percent: the confusion that causes most arguments Everything below is what sits behind that. Posting the method first, because I know…
|
+10 | 14 | 2.1k | 2mo |
|
Light exposure: how much protection is proportionate?
The question in the title: Light exposure: how much protection is proportionate? I will give what I have already checked below so nobody repeats it. A question about technique rather than about dose. I have…
|
2 | 59 | 3mo | |
|
Reflectance and photometric devices: precision in practice — a second dataset
Reflectance and photometric devices: precision in practice — a second dataset — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I…
|
+75 | 82 | 17k | 12h |
|
Chain of custody for a sample you posted yourself
Chain of custody for a sample you posted yourself Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…
|
2 | 7.3k | 5h | |
|
Second pass at: Why chargeback is not the safety net people assume
Second pass at: Why chargeback is not the safety net people assume Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually…
|
2 | 25k | 3mo | |
|
Specificity, linearity, accuracy, precision, range, robustness — with real criteria
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this…
|
+44 | 48 | 12k | 1d |
|
Washout with a one-week half-life: the arithmetic — does this still hold?
Washout with a one-week half-life: the arithmetic — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SURPASS-2 ( N Engl J Med , 2021)…
|
+41 | 45 | 12k | 1d |
|
Revisiting: Can a home kit substitute for a laboratory report? A careful no
Revisiting: Can a home kit substitute for a laboratory report? A careful no — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it…
|
+50 | 56 | 9.8k | 1d |
|
Journal club: is percentage weight change the right endpoint?
Journal club: is percentage weight change the right endpoint? I have a specific reason for asking rather than idle curiosity, and the context is below. Comparing SURPASS-4 ( Lancet , 2021) with SURMOUNT-OSA (…
|
+116 | 120 | 23k | 3mo |
|
The anatomy of a question that gets answered within an hour
The anatomy of a question that gets answered within an hour — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have tried to include the things…
|
+113 | 127 | 2.7k | 13h |
|
Second pass at: Sleep apnoea improving and the equipment implications
On the subject in the title: Second pass at: Sleep apnoea improving and the equipment implications Working notes rather than a conclusion. General question, not a request for advice about my own care — I know…
|
+89 | 96 | 1.1k | 10h |
|
Fasting versus non-fasting and which tests care
Fasting versus non-fasting and which tests care Writing it up because I had to work it out twice and would rather nobody else did. General question, not a request for advice about my own care — I know the…
|
+72 | 78 | 14k | 19h |
|
Journal club: the CagriSema phase 2 combination paper
On the subject in the title: Journal club: the CagriSema phase 2 combination paper Working notes rather than a conclusion. I have seen SURMOUNT-1 ( N Engl J Med , 2022) cited in support of a claim I do not…
|
2 | 329 | 21h | |
|
Coming back to: Which fields on a certificate actually matter, ranked
Which fields on a certificate actually matter, ranked I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first three…
|
2 | 15k | 4mo | |
|
Follow-up: Levothyroxine timing: a real interaction with a simple fix
On the subject in the title: Levothyroxine timing: a real interaction with a simple fix Working notes rather than a conclusion. Reporting something rather than asking about it, in case the pattern is useful…
|
+2 | 6 | 8.1k | 4mo |
|
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about a population rather…
|
+17 | 22 | 4.5k | 1d |
|
What a documentation review can and cannot tell you — a second dataset
The question in the title: What a documentation review can and cannot tell you — a second dataset I will give what I have already checked below so nobody repeats it. I would like to talk about documentation…
|
4 | 170 | 4mo | |
|
Secretagogues and glucose tolerance: the mechanistic concern — what changed since
Secretagogues and glucose tolerance: the mechanistic concern — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I have seen STEP 1 ( N Engl J Med , 2021)…
|
+2 | 6 | 31k | 2mo |
|
Spreadsheets: an appreciation — what changed since
Spreadsheets: an appreciation — what changed since — setting out what I have, and where I think it stops being reliable. Lower-stakes topic, but the sourcing rule still applies if anyone makes a claim.…
|
+102 | 113 | 26k | 17h |
|
Why the absence of controlled human data on BPC-157 matters more than people admit
Why the absence of controlled human data on BPC-157 matters more than people admit — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing STEP 8 ( JAMA , 2022) with…
|
+60 | 66 | 16k | 1d |